Evidence map›Paper›PMID 40703276›Full record

ArticleFrontiers in medicine2025

Visual outcomes with two posterior chamber phakic intraocular lenses in myopic patients: a contralateral eye study.

Boliang Li, Xun Chen, Mingrui Cheng, I-Chun Lin, Yinjie Jiang, Yadi Lei, Guanghan Xu, Mingwei Li, Zhiwei Mao, Xingtao Zhou and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Boliang Li *Eye Ear Nose and Throat Hospital, Fudan University, Shanghai, China.
Xun Chen *Eye Ear Nose and Throat Hospital, Fudan University, Shanghai, China.
Mingrui ChengEye Ear Nose and Throat Hospital, Fudan University, Shanghai, China.
I-Chun LinEye Ear Nose and Throat Hospital, Fudan University, Shanghai, China.
Yinjie JiangEye Ear Nose and Throat Hospital, Fudan University, Shanghai, China.
Yadi LeiEye Ear Nose and Throat Hospital, Fudan University, Shanghai, China.
Guanghan XuEye Ear Nose and Throat Hospital, Fudan University, Shanghai, China.
Mingwei LiEye Ear Nose and Throat Hospital, Fudan University, Shanghai, China.
Zhiwei MaoEye Ear Nose and Throat Hospital, Fudan University, Shanghai, China.
Xingtao ZhouEye Ear Nose and Throat Hospital, Fudan University, Shanghai, China.
Xiaoying WangEye Ear Nose and Throat Hospital, Fudan University, Shanghai, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: Assess the efficacy, safety, and visual quality of two posterior chamber phakic intraocular lenses (PIOL) for myopia correction. Methods: In this randomized double-blind prospective controlled trial, 38 eyes of 19 myopic patients received phakic refractive (PR) IOL in one eye and implantable collamer lens (EVO ICL) in the opposite eye and were followed up for 1 year. Uncorrected distance visual acuity, corrected distance visual acuity, vault, disk halo size, contrast sensitivity, higher-order aberrations, retinal imaging quality, intraocular scattering, and subjective glare/halo perception were measured. Results: At 1 year, mean efficacy indices were 1.03 ± 0.16 (PR) and 1.01 ± 0.15 (ICL), and mean safety indices were 1.18 ± 0.07 (PR) and 1.15 ± 0.09 (ICL). The PR group had lower vaults than those of the ICL group at 1 year (342.63 ± 153.94 vs. 470.00 ± 230.31 μm, Conclusion: Phakic refractive implantation is a safe and effective treatment option for myopia. The PR group exhibited lower vaults than those of the ICL group. The PR group had milder glare/halo in the early postoperative period compared to the ICL group, though long-term differences were not significant.

Indexed as

implantable collamer lensmyopiaPIOLrefractive outcomesvisual quality

Identifiers

PMID40703276
PMCPMC12283568

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.